In a filing, Soleno Therapeutics Inc revealed its CHIEF EXECUTIVE OFFICER Anish Bhatnagar unloaded Company’s shares for reported $0.78 million on Apr 01 ’24. In the deal valued at $41.34 per share,18,980 shares were sold. As a result of this transaction, Anish Bhatnagar now holds 152,790 shares worth roughly $5.77 million.
Then, Mackaness James H sold 5,175 shares, generating $213,937 in total proceeds. Upon selling the shares at $41.34, the CHIEF FINANCIAL OFFICER now owns 62,953 shares.
Before that, Yen Kristen sold 2,218 shares. Soleno Therapeutics Inc shares valued at $91,694 were divested by the insider at a price of $41.34 per share. As a result of the transaction, Yen Kristen now holds 23,422 shares, worth roughly $0.89 million.
Piper Sandler initiated its Soleno Therapeutics Inc [SLNO] rating to an Overweight in a research note published on February 05, 2024; the price target was $93. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Guggenheim started covering the stock on September 29, 2020. It rated SLNO as “a Buy”.
Price Performance Review of SLNO
On Tuesday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock fall -1.90% to $37.79. Over the last five days, the stock has lost -8.03%. Soleno Therapeutics Inc shares have fallen nearly -6.11% since the year began. Nevertheless, the stocks have risen 1069.97% over the past one year. While a 52-week high of $53.82 was reached on 02/28/24, a 52-week low of $3.00 was recorded on 01/04/24. SMA at 50 days reached $44.67, while 200 days put it at $27.09. A total of 0.31 million shares were traded, compared to the trading of 0.29 million shares in the previous session.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 37.19, which if violated will result in even more drops to 36.60. On the upside, there is a resistance level at 38.59. A further resistance level may holdings at 39.40. The Relative Strength Index (RSI) on the 14-day chart is 35.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.04%. Stochastics %K at 13.32% indicates the stock is a buying.
The most recent change occurred on January 10, 2020 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
